Stocks and Investing Stocks and Investing
Tue, February 1, 2022
[ 12:00 AM ] - WOPRAI
Nicole Deblase Maintained (TT) at Hold with Decreased Target to $184 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Brett Linzey Maintained (TT) at Hold with Decreased Target to $180 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Andrew Kaplowitz Maintained (TT) at Strong Buy with Decreased Target to $228 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Nigel Coe Maintained (TT) at Hold with Decreased Target to $202 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Giacomo Romeo Maintained (XOM) at Hold and Held Target at $62 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Brian Ossenbeck Maintained (UPS) at Buy and Held Target at $243 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Michael Sison Maintained (CE) at Buy with Decreased Target to $200 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Maintained (CE) at Buy with Increased Target to $206 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (SRPT) at Hold with Decreased Target to $71 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Weston Twigg Maintained (SPIR) at Hold with Decreased Target to $34 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Benjamin Swinburne Maintained (SPOT) at Buy with Decreased Target to $300 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Jed Kelly Initiated (SOND) at Buy and Held Target at $240 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Tayo Okusanya Initiated (DOC) at Hold and Held Target at $19 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Mark Kelley Initiated (SNAP) at Strong Buy and Held Target at $45 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Jake Bartlett Initiated (SYY) at Strong Buy and Held Target at $89 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Deane Dray Maintained (ATKR) at Buy with Increased Target to $139 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Matthew Sharpe Maintained (BAH) at Buy with Decreased Target to $93 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (AXP) at Buy with Increased Target to $218 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Kurt Yinger Upgraded (AZEK) to Strong Buy on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Matthew Sharpe Maintained (CACI) at Hold with Decreased Target to $286 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
James Fotheringham Maintained (CACC) at Hold with Increased Target to $428 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Austin Wurschmidt Initiated (AMH) at Hold on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Emmanuel Rosner Upgraded (ALV) to Strong Buy and Increased Target to $123 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Daniel Jester Initiated (BILL) at Buy and Held Target at $209 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Daniel Jester Initiated (BL) at Hold and Held Target at $92 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Simon Baker Upgraded (BNTX) to Hold on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BNTX) at Hold with Decreased Target to $217 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
David Lebovitz Maintained (BPMC) at Hold with Decreased Target to $92 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Marc Goodman Initiated (AMLX) at Buy and Held Target at $50 on, Feb 1st, 2022
[ 12:00 AM ] - WOPRAI
Chris Shibutani Initiated (AMLX) at Strong Buy and Held Target at $36 on, Feb 1st, 2022

Chris Shibutani Initiated (AMLX) at Strong Buy and Held Target at $36 on, Feb 1st, 2022


Published on 2024-10-27 19:30:50 - WOPRAI, Chris Shibutani
  Print publication without navigation


Chris Shibutani of Goldman Sachs, Initiated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $36 on, Feb 1st, 2022.

Chris, nor any peers, have made any analyst calls on AMLX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources